XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.2

Net Income (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Schedule of Diluted Net Income (Loss) Per Share

The following tables reconcile the components of the numerator and denominator included in the calculation of diluted net income (loss) per share:

						Three Months Ended September 30,
						2021						2020
Numerator
Net income (loss) attributed to Inovio Pharmaceuticals, Inc. (numerator for use in basic and diluted net income (loss) per share)						$	(60,169,041)					$	19,171,336
Denominator
Weighted average number of common shares outstanding (denominator for use in basic net income (loss) per share)						210,304,836						165,355,540
Effect of dilutive potential common shares						—						9,020,862
Denominator for use in diluted net income (loss) per share						210,304,836						174,376,402
Net income (loss) per share, diluted						$	(0.29)					$	0.11
Net income (loss) per share, basic						$	(0.29)					$	0.12

						Nine Months Ended September 30,
						2021						2020
Numerator
Net loss attributed to Inovio Pharmaceuticals, Inc. (numerator for use in basic and diluted net loss per share)						$	(196,711,130)					$	(142,072,777)
Denominator
Weighted average number of common shares outstanding (denominator for use in basic net loss per share)						207,455,684						148,656,454
Effect of dilutive potential common shares						—						—
Denominator for use in diluted net loss per share						207,455,684						148,656,454
Net loss per share, diluted						$	(0.95)					$	(0.96)
Net loss per share, basic						$	(0.95)					$	(0.96)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes potential shares of common stock that were excluded from the diluted net income (loss) per share calculation because of their anti-dilutive effect for the three months ended September 30, 2021 and 2020:

Common Stock Equivalents			2021						2020
Options to purchase common stock			10,462,252						119,438
Service-based restricted stock units			2,446,102						—
Performance-based restricted stock units			663,353						—
Convertible preferred stock			3,309						3,309
Convertible notes			3,049,980						11,039,574
December 2019 Bonds			—						1,009,450
Total			16,624,996						12,171,771

The following table summarizes potential shares of common stock that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the nine months ended September 30, 2021 and 2020:

Common Stock Equivalents			2021						2020
Options to purchase common stock			10,462,252						9,290,347
Service-based restricted stock units			2,446,102						2,586,915
Performance-based restricted stock units			663,353						663,353
Convertible preferred stock			3,309						3,309
Convertible notes			3,049,980						11,039,574
December 2019 Bonds			—						1,009,450
Total			16,624,996						24,592,948

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration